Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences Limited
02 1Dr.Reddy's Laboratories Limited
03 1Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
04 1Aurobindo Pharma Limited
05 1CTX Lifesciences Pvt. Ltd.
06 1Dasami Lab Private Limited
07 1Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
08 1Jubilant Pharmova Limited
09 1Lonza AG
10 1MSN Life Sciences Private Limited
11 1Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
01 1ESLICARBAZEPINE ACETATE
02 1Eslicarbazepin acetate
03 5Eslicarbazepine Acetate
04 2Eslicarbazepine acetate
05 2eslicarbazepine acetate
01 2China
02 7India
03 1Taiwan
04 1U.S.A
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1005
Start Marketing Date : 2016-05-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-933
Start Marketing Date : 2017-05-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6269
Start Marketing Date : 2021-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-482
Start Marketing Date : 2023-12-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69875-8038
Start Marketing Date : 2023-11-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42419-026
Start Marketing Date : 2016-01-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51508-014
Start Marketing Date : 2023-08-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1170
Start Marketing Date : 2013-02-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49187-0832
Start Marketing Date : 2011-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-051
Start Marketing Date : 2018-04-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Eslicarbazepine Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eslicarbazepine Acetate, including repackagers and relabelers. The FDA regulates Eslicarbazepine Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eslicarbazepine Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eslicarbazepine Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eslicarbazepine Acetate supplier is an individual or a company that provides Eslicarbazepine Acetate active pharmaceutical ingredient (API) or Eslicarbazepine Acetate finished formulations upon request. The Eslicarbazepine Acetate suppliers may include Eslicarbazepine Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Eslicarbazepine Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eslicarbazepine Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eslicarbazepine Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eslicarbazepine Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eslicarbazepine Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eslicarbazepine Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eslicarbazepine Acetate suppliers with NDC on PharmaCompass.
We have 11 companies offering Eslicarbazepine Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
